Crizotinib
Drug timelines are a Plus or Pro feature.
55 regulatory and trial events tracked for Crizotinib, covering 2011-10-19 to 2025-11-21. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Repotrectinib Versus Crizotinib in Participants With Locally Advanced or Metastatic Tyrosine Kinase Inhibitor (TKI)-naïve ROS1-positive Non-Small Cell Lung Cancer (NSCLC) (TRIDENT-3) [Phase 3]